diabetes glp-1 agonist Receptor Agonists: A Game-Changer for Type 2 Understanding GLP-1 receptor agonists and

Nat Rev Nephrol 13:605 Skov J (2014) Effects of GLP-1 in the Kidney

Abstract Non-alcoholic fatty liver disease and steatohepatitis are highly associated with obesity and type 2 diabetes mellitus

doi: 10.1016/j.ijcard.2015.12.009

It helps regulate blood sugar, slows stomach emptying and contributes to feelings of fullness

Taken together, these observations suggest that a reduction in the deceleration of gastric emptying may occur even within 4 hours of administration of exogenous GLP-1RAs (20)

For instance, Liraglutide(1.83 mg) showed relatively lower efficacy, with a weight reduction of only 4.03 kg over 52 weeks compared to the placebo, whereas Retatrutide(6.5 mg) exhibited the highest efficacy, achieving a weight reduction of 13.2 kg compared to the placebo over the same period